| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 02/06/2001 | US6184361 Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| 02/06/2001 | US6183744 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 02/06/2001 | US6183725 Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method |
| 02/06/2001 | US6183724 Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them |
| 02/06/2001 | US6183722 A cyclic peptide derivatives for use in therapeutic reagents and radiotherapeutic reagents and radiodiagnostic reagents; a somatostatin receptor-binding peptide |
| 02/06/2001 | US6183721 A radioactive cyclic octapeptides for radiotherapy of somatostatin receptor positive tumors; antitumor agents |
| 02/06/2001 | US6183409 Soft x-ray emitting radioactive stent |
| 02/01/2001 | WO2001007414A1 Preparation of compounds useful for the detection of hypoxia |
| 02/01/2001 | WO2001007089A2 Technetium tc99m teboroxime myokardial-perfusion mittel |
| 02/01/2001 | WO1999066951A8 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 01/31/2001 | EP1071684A1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS |
| 01/31/2001 | EP1071475A2 Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections |
| 01/31/2001 | EP0799054B1 Conjugate for treating inflammatory diseases |
| 01/30/2001 | US6180648 Analogs of cocaine |
| 01/30/2001 | US6180414 Breath test for detection of drug metabolism |
| 01/30/2001 | US6180083 Tropane derivatives useable in particular for in vivo detection of dopamine transporters |
| 01/30/2001 | US6180082 Administration of a radioisotopic compound by infusion over a period of time greater than two hours, preferably greater than twelve hours, greatly increases the maximum radioactivity that accumulates in the target cell |
| 01/30/2001 | CA2200482C Modified radioantibody fragments for reduced renal uptake |
| 01/30/2001 | CA2177604C Labelling of nucleic acid analogue-peptide chimerae |
| 01/30/2001 | CA2171124C A radioactive patch/film and process for preparation thereof |
| 01/30/2001 | CA2124458C Technetium-99m labeled peptides for imaging |
| 01/30/2001 | CA2101942C Technetium-99m labeled polypeptides for imaging |
| 01/30/2001 | CA2011171C Biodegradable poly (phosphate esters) |
| 01/30/2001 | CA1341176C Macrocylic compounds |
| 01/25/2001 | WO2001005968A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/25/2001 | WO2001005831A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | WO2001005805A2 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 01/25/2001 | WO2001005439A1 Radiodetection and therapy of aberrant cell proliferation |
| 01/25/2001 | WO2001005433A2 Delivery and retention of activity agents to lymph nodes |
| 01/25/2001 | WO2001005383A2 Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 01/25/2001 | WO2000066183A8 Vascular embolic materials having multifunctions |
| 01/25/2001 | CA2379391A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | CA2340721A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/24/2001 | EP1069919A2 Stimulus sensitive gel with radioisotope and methods of making |
| 01/24/2001 | EP1069918A1 Enhancement of cellular gallium uptake |
| 01/24/2001 | EP1069888A1 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters |
| 01/23/2001 | US6177551 Bridged aromatic substituted amine ligands with donor atoms |
| 01/23/2001 | US6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 01/18/2001 | WO2001003745A2 Therapy and diagnosis of colorectal cancer with radiopharmaceuticals |
| 01/18/2001 | WO2001003734A1 Blocking immune response to a foreign antigen using an antagonist which binds to cd20 |
| 01/18/2001 | WO2000045627B1 Radioactive transition metal stents |
| 01/18/2001 | WO2000035492A3 Vitronectin receptor antagonist pharmaceuticals |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | DE19934088A1 Neue C-19-halogensubstituierte Steroide der Androst-9(11)-en-Reihe, Verfahren zu ihrer Herstellung sowie ihre Verwendung New C-19 halogen-substituted steroids of androst-9 (11) -en-series, processes for their preparation and their use |
| 01/18/2001 | DE19933346A1 Stabile radioactively-marked nanoparticles bound to other molecules for use in medical and diagnostic techniques, particularly used for studying phagocyte processes |
| 01/18/2001 | CA2379274A1 Blocking immune response to a foreign antigen using an antagonist which binds to cd20 |
| 01/17/2001 | EP1068224A2 Pharmaceuticals for the imaging of angiogenic disorders |
| 01/17/2001 | EP1068222A1 Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer |
| 01/17/2001 | EP1068204A1 8-azabicyclo 3.2.1]oct-2-ene derivatives in labelled and use of 8-azabicyclo 3.2.1]oct-2-ene derivatives in labelled and unlabelled form |
| 01/17/2001 | EP1067972A1 Multicomponent complex for use with a substrate |
| 01/17/2001 | EP1067971A1 Inorganic material for radioactive drug delivery |
| 01/17/2001 | EP1067970A2 Diagnostic imaging of vascular abnormalities using vasomodification |
| 01/17/2001 | EP1043928A4 Methods and compositions for treating and diagnosing tumors using adenosine receptor activated cells |
| 01/17/2001 | CN1280013A Brain perfusion developer 99m TCN (CHDT)2 and its preparing method |
| 01/16/2001 | US6174730 Administering carbon-13 labeled aromatic amino acid, alanine, methionine, fructose, or galactose before surgery; measuring level in exhaled carbon dioxide; administering labeled compound after surgery; measuring level; comparing values |
| 01/16/2001 | US6174513 A storage stable therapeutic composition comprising one or more surfactants to prevent radiolysis during storage; producing therapeutic effects on targeted tissues |
| 01/16/2001 | CA2164707C Technetium-99m labeled peptides for imaging inflammation |
| 01/16/2001 | CA2075297C Method for producing actinium-225 and bismuth-213 |
| 01/16/2001 | CA2010800C Protein labelling |
| 01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | WO2001002022A1 New melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma |
| 01/11/2001 | WO2001002021A2 A radiolabeled mammalian tachykinin peptide analogue |
| 01/11/2001 | CA2376513A1 An interleukin-1 receptor antagonist and uses thereof |
| 01/10/2001 | CN1060397C Magnetic resonance contrast medium for gastrointestinal tract |
| 01/09/2001 | US6172045 Cluster clearing agents |
| 01/09/2001 | US6171795 Nucleic acid ligands to CD40ligand |
| 01/09/2001 | US6171588 Anti-αvβ3 integrin antibody antagonists |
| 01/09/2001 | US6171578 Glycoprotein iib/iiia receptor-binding benzodiazepine derivatives covalently linked to metal ion chelators. |
| 01/09/2001 | US6171577 Accessible sulfhydryl group; and hexose moiety recognized by a mammalian liver receptor, wherein the hexose moiety is conjugated to the annexin. |
| 01/09/2001 | US6171576 Tropane compound is linked through the n atom at the 8-position to a chelating ligand capable of complexing technetium or rhenium to produce a neutral labeled complex that selectively binds to the dopamine transporter. |
| 01/09/2001 | US6171575 Method of radioisotopic assessment of the integrity and function of the nose-brain barrier |
| 01/04/2001 | WO2001000637A1 Group (vii) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them |
| 01/04/2001 | WO2001000621A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
| 01/04/2001 | WO2001000604A1 Brain sigma-1 receptor-binding ligand |
| 01/04/2001 | WO2001000247A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/04/2001 | WO2001000082A1 Imaging the dopamine transporter to determine ad-hd |
| 01/04/2001 | WO2000053236A3 Methods and compositions for targeted drug delivery |
| 01/04/2001 | CA2377154A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
| 01/04/2001 | CA2377018A1 Group (vii) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them |
| 01/04/2001 | CA2376859A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/03/2001 | EP1064953A2 Contrast media for diagnostic imaging comprising gas-filled microspheres |
| 01/03/2001 | CN1278808A Process for the selective oxidation of organic compounds |
| 01/03/2001 | CN1278447A Pharmaceutical kit with 1-hydroxy ethylidene diphosphonate and its preparation and use |
| 01/02/2001 | US6168777 In vivo delivery of radioactive compositions which are delivered as a fluid to the solid mass tumor; subsequent solidification of this composition in the prostate results in delivery of a controlled amount of radiation to the prostate. |
| 12/28/2000 | WO2000078796A2 Labeled neurotensin derivatives with improved resistance to enzymatic degradation |
| 12/28/2000 | WO2000078774A2 Induction of pharmacological stress with adenosine receptor agonists |
| 12/28/2000 | WO2000078364A2 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 12/28/2000 | WO2000078363A1 Radiolabeled farnesyl-protein transferase inhibitors |
| 12/28/2000 | WO2000078362A2 Stable, radioactively marked nanoparticles, method for the production and utilization thereof |
| 12/28/2000 | WO2000078361A2 Methods of imaging and targeting tumor vasculature |
| 12/28/2000 | WO2000078355A2 Biologically active materials |
| 12/28/2000 | WO2000078352A1 Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method |
| 12/28/2000 | WO2000032240A3 Radioconjugation of internalizing antibodies |
| 12/28/2000 | DE19928496A1 Stabile radioactively-marked nanoparticles bound to other molecules for use in medical and diagnostic techniques, particularly used for studying phagocyte processes |
| 12/28/2000 | CA2378051A1 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 12/28/2000 | CA2377188A1 Methods of imaging and targeting tumor vasculature |
| 12/28/2000 | CA2374548A1 Biologically active materials |
| 12/28/2000 | CA2374270A1 Labeled neurotensin derivatives |
| 12/27/2000 | EP1061959A2 Radioimmuno-pharmacon for treating the hiv-1 infection |
| 12/27/2000 | EP1061958A2 Radioactive seed implants |